Apellis Pharmaceuticals
Biotechnology Research
Overview
Overview
Industry
Founded Year
2008
Company Type
Public Company
Website
https://apellis.com/
Social Media
Specialty
Amyotrophic Lateral Sclerosis (ALS), C3 Glomerulopathy (C3G), COPD, Cold Agglutinin Disease (CAD), Complement System, Gene Therapy, Geographic Atrophy (GA), Hematology, Nephrology, Neurology, Ophthalmology, Paroxysmal Nocturnal Hemoglobinuria (PNH), Targeted C3 Therapies, asthma, early stage drug development, immunology, paroxysmal nocturnal hemoglobinuria, peptide drugs
Overview
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the c read more company news read more company news read more company news read more company news...
FAQs
When was Apellis Pharmaceuticals founded?
Apellis Pharmaceuticals was founded in 2008.
What is Apellis Pharmaceuticals's official website?
Apellis Pharmaceuticals's official website is https://apellis.com/.
Find Contacts Everywhere
Find emails and phone numbers on LinkedIn, Company Websites and Your CRM!
